Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Clinical Follow-up Study of the G7 Freedom Constrained Neutral Liner and G7 Neutral +5mm Liner in Primary and Revision Total Hip Arthroplasty (Implants and Instrumentation)

NCT04093739 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT04093739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04093739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Clinical Follow-up Study of the G7 Freedom Constrained Neutral Liner and G7 Neutral +5mm Liner in Primary and Revision Total Hip Arthroplasty (Implants and Instrumentation)
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Withdrawn
Start date
April 1, 2022
Completion date
June 30, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hip disease, hip fractures, hip injuries, hip osteoarthritis